Bae Sung Uk, Park Jin Seok, Choi Young Jin, Lee Min Ku, Cho Byung Sun, Kang Yoon Jung, Park Joo Seung, Kim Chang Nam
Division of Colorectal Surgery, Department of Surgery, Colorectal Cancer Clinic, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Department of Surgery, Eulji University Hospital, Daejeon, Korea.
Ann Coloproctol. 2014 Feb;30(1):11-7. doi: 10.3393/ac.2014.30.1.11. Epub 2014 Feb 28.
The purpose of this study is to evaluate the perioperative and long-term oncologic outcomes of hand-assisted laparoscopic surgery (HALS) and standard laparoscopic surgery (SLS) and assess the role of HALS in the management of right-sided colon cancer.
The study group included 53 patients who underwent HALS and 45 patients who underwent SLS for right-sided colon cancer between April 2002 and December 2008.
The patients in each group were similar in age, American Society of Anesthesiologist (ASA) score, body mass index, and history of previous abdominal surgeries. Eight patients in the HALS group and no patient in the SLS group exhibited signs of tumor invasion into adjacent structures. No differences were noted in the time to return of normal bowel function, time to toleration of diet, lengths of hospital stay and narcotic usage, and rate of postoperative complications. The median incision length was longer in the HALS group (HALS: 7.0 cm vs. SLS: 4.8 cm, P < 0.001). The HALS group had a significantly higher pathologic TNM stage and significantly larger tumor size (HALS: 6.0 cm vs. SLS: 3.3 cm, P < 0.001). The 5-year overall, disease-free, and cancer-specific survival rates of the HALS and the SLS groups were 87.3%, 75.2%, and 93.9% and 86.4%, 78.0%, and 90.7%, respectively (P = 0.826, P = 0.574, and P = 0.826).
Although patients in the HALS group had more advanced disease and underwent more complex procedures than those in the SLS group, the short-term benefits and the oncologic outcomes between the two groups were comparable. HALS can, therefore, be considered an alternative to SLS for bulky and fixed right-sided colon cancer.
本研究旨在评估手辅助腹腔镜手术(HALS)和标准腹腔镜手术(SLS)的围手术期及长期肿瘤学结局,并评估HALS在右侧结肠癌治疗中的作用。
研究组包括2002年4月至2008年12月期间因右侧结肠癌接受HALS的53例患者和接受SLS的45例患者。
每组患者在年龄、美国麻醉医师协会(ASA)评分、体重指数及既往腹部手术史方面相似。HALS组有8例患者、SLS组无患者出现肿瘤侵犯相邻结构的征象。两组在正常肠功能恢复时间、饮食耐受时间、住院时间、麻醉药物使用及术后并发症发生率方面无差异。HALS组的中位切口长度更长(HALS:7.0 cm vs. SLS:4.8 cm,P < 0.001)。HALS组的病理TNM分期显著更高,肿瘤大小显著更大(HALS:6.0 cm vs. SLS:3.3 cm,P < 0.001)。HALS组和SLS组的5年总生存率、无病生存率及癌症特异性生存率分别为87.3%、75.2%、93.9%和86.4%、78.0%、90.7%(P = 0.826、P = 0.574、P = 0.826)。
尽管HALS组患者的疾病比SLS组更晚期,手术过程更复杂,但两组的短期获益和肿瘤学结局相当。因此,对于体积较大且固定的右侧结肠癌,HALS可被视为SLS的替代方法。